LeMaitre Vascular, Inc. (LMAT)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

LeMaitre Vascular, Inc. (LMAT) is up 13.5% since the beginning of the year. At $92 per share, LMAT is trading 22.4% below its 52-week high of $118. Investors who bought $1,000 worth of LMAT shares 5 years ago would now be looking at an investment worth $1,873.

LeMaitre Vascular, Inc. (LMAT) has returned 13.51% so far this year and 15.00% over the past 12 months. Looking at the last ten years, LMAT has achieved an annualized return of 21.12%, outperforming the S&P 500 Index benchmark, which averaged 13.75% per year.

Based on dividend-adjusted daily data since Oct 19, 2006, LMAT's average daily return is +0.10%, while the average monthly return is +1.69%. At this rate, an investment would double in approximately 3.4 years.

Historically, 59% of months were positive and 41% were negative. The best month was Apr 2008 with a return of +28.6%, while the worst month was Mar 2008 at -31.6%. The longest winning streak lasted 7 consecutive months, and the longest losing streak was 6 months.

On a daily basis, LMAT closed higher 49% of trading days. The best single day was Jan 5, 2009 with a return of +31.2%, while the worst single day was Oct 14, 2008 at -26.0%.

LeMaitre Vascular, Inc. has an annualized alpha of 22.01%, beta of 0.55, and R2 of 0.05 versus S&P 500 Index. Calculated based on daily prices since October 20, 2006.

• This stock participates in less of S&P 500 Index's moves in both directions, but captures a larger share of gains (99.85%) than losses (69.86%) - typical of diversified or defensive assets.
• Beta of 0.55 may look defensive, but with R2 of 0.05 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
• R2 of 0.05 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

LMAT ranks 54 for risk / return — on par with similar stocks. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.

The table below present risk-adjusted performance metrics for LeMaitre Vascular, Inc. (LMAT) and compare them to S&P 500 Index.

LeMaitre Vascular, Inc. provided a 0.98% dividend yield over the last twelve months, with an annual payout of $0.90 per share. The company has been increasing its dividends for 14 consecutive years.

The table displays the monthly dividend distributions for LeMaitre Vascular, Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the LeMaitre Vascular, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the LeMaitre Vascular, Inc. was 75.69%, occurring on Dec 23, 2008. Recovery took 1217 trading sessions.

The current LeMaitre Vascular, Inc. drawdown is 21.76%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of LeMaitre Vascular, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how LeMaitre Vascular, Inc. is priced in the market compared to other companies in the Medical Instruments & Supplies industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.